Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001171843-19-002720
Filing Date
2019-04-29
Accepted
2019-04-29 16:46:16
Documents
4
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 S-8 s8_042919.htm S-8 48560
2 EXHIBIT 5.1 exh_51.htm EX-5.1 7123
3 EXHIBIT 23.1 exh_231.htm EX-23.1 2409
4 EXHIBIT 99.1 exh_991.htm EX-99.1 80533
  Complete submission text file 0001171843-19-002720.txt   139661
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-231108 | Film No.: 19776601
SIC: 2836 Biological Products, (No Diagnostic Substances)